Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
175.97B | 177.03B | 165.20B | 133.78B | 113.66B | 137.40B | Gross Profit |
34.47B | 35.38B | 30.63B | 24.81B | 20.56B | 26.48B | EBIT |
13.15B | 14.69B | 11.17B | 7.57B | 4.95B | 9.39B | EBITDA |
18.19B | 23.34B | 16.72B | 12.61B | 10.06B | 13.49B | Net Income Common Stockholders |
12.13B | 12.42B | 8.28B | 5.49B | 4.33B | 6.44B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
8.94B | 8.48B | 4.43B | 5.01B | 5.30B | 3.79B | Total Assets |
181.62B | 179.02B | 163.34B | 142.69B | 130.35B | 126.94B | Total Debt |
40.55B | 36.88B | 39.38B | 34.20B | 32.78B | 34.72B | Net Debt |
31.61B | 28.40B | 34.96B | 29.18B | 27.48B | 30.93B | Total Liabilities |
83.36B | 86.32B | 85.48B | 73.61B | 67.07B | 69.71B | Stockholders Equity |
91.72B | 87.17B | 73.53B | 65.34B | 60.09B | 54.22B |
Cash Flow | Free Cash Flow | ||||
0.00 | 6.84B | -3.56B | 468.00M | 4.30B | 1.69B | Operating Cash Flow |
0.00 | 13.72B | 1.00B | 4.12B | 10.08B | 9.07B | Investing Cash Flow |
0.00 | -3.59B | -4.51B | -3.61B | -4.95B | -7.04B | Financing Cash Flow |
0.00 | -6.24B | 2.86B | -1.02B | -3.61B | -3.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $317.27B | 9.73 | 15.22% | 2.19% | 4.18% | 29.24% | |
79 Outperform | ¥947.76B | 10.25 | 13.91% | 3.59% | 6.27% | 13.96% | |
76 Outperform | $502.71B | 9.52 | 7.66% | 3.63% | 7.01% | 39.29% | |
71 Outperform | ¥90.70B | 6.84 | 4.13% | -0.62% | -3.02% | ||
66 Neutral | $123.55B | 13.78 | 4.61% | 3.11% | -0.22% | 76.75% | |
64 Neutral | $413.75B | 7.30 | 9.42% | 2.10% | 4.44% | 409.76% | |
50 Neutral | $1.98B | -1.06 | -21.29% | 3.61% | 1.95% | -30.61% |